Price Target Update on GlaxoSmithKline PLC (NYSE:GSK)

GlaxoSmithKline PLC (NYSE:GSK) : Average target price received by GlaxoSmithKline PLC (NYSE:GSK) is $48.5 with an expected standard deviation of $0.71. The most aggressive target on the stock is $49, whereas the most downbeat target is $48. 2 financial analysts are currently covering the stock.

Other Equity analysts have also commented on the company shares. Cantor Fitzgerald initiates coverage on GlaxoSmithKline PLC (NYSE:GSK) The brokerage firm has issued a Hold rating on the shares. The rating by the firm was issued on February 26, 2016.

GlaxoSmithKline PLC (NYSE:GSK): stock turned positive on Thursday. Though the stock opened at $42.57, the bulls momentum made the stock top out at $42.59 level for the day. The stock recorded a low of $41.98 and closed the trading day at $42.56, in the green by 1.92%. The total traded volume for the day was 3,259,016. The stock had closed at $41.76 in the previous days trading.

The company shares have dropped -4.02% from its 1 Year high price. On Aug 6, 2015, the shares registered one year high at $45.49 and the one year low was seen on Sep 29, 2015. The 50-Day Moving Average price is $42.02 and the 200 Day Moving Average price is recorded at $40.86.

GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSKs Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSKs Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.